Alemtuzumab is a recombinant DNA-derived humanized IgG1 kappa monoclonal antibody that is directed against the 21-28 kDa cell surface glycoprotein CD52. Alemtuzumab does not cross-react with mouse CD52, making in vivo studies in wild-type mice unfeasible.
Molecular Weight:
145451.73
Purity:
>98%
CAS Number:
[216503-57-0]
Formula:
C6468H10066N1732O2005S40
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted